Gilead’s HIV prevention treatment found 100% effective in late-stage trial 20 de junho de 2024 by in News Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 20 de junho de 2024